GSK plc stock (GB0009252882): analysts see modest upside

GSK plc ended the week with a fresh Sunday technical backdrop, while market data still points to a hold-style consensus and a share price below the average analyst target.

GSK plc shares closed the week with a Sunday technical lens on the London market, where the stock last traded at GBX 1,881.50 on 05/29/2026, according to MarketBeat's market data page as of 05/29/2026. The latest consensus on the London-listed stock shows a hold view and an average 12-month target of GBX 2,034.29, leaving the shares below the current Street average.

For investors watching the United Kingdom's FTSE 100 healthcare names, the key home-country reference point remains the LSE listing rather than any overseas trading venue. GSK also continues to draw attention from income-focused holders after recent dividend data showed an annual payout of $1.77 per share and a 3.51% yield, with the last ex-dividend date on 05/15/2026.

As of: 05/31/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: GSK
• Sector/industry: Pharmaceuticals and biotechnology
• Headquarters/country: London, United Kingdom
• Core markets: United Kingdom, United States, Europe, and other international markets
• Key revenue drivers: Vaccines, specialty medicines, and general medicines
• Home exchange/listing venue: London Stock Exchange (GSK)
• Trading currency: GBP

GSK plc: core business model

GSK sells prescription medicines and vaccines, with revenue led by its current pharmaceuticals and vaccine franchises rather than any divested consumer-health operations.

Chart technicals and 52-week range

The Sunday technical setup is framed by a 52-week range of 1,315.00 to 2,282.00, which indicates that the shares still trade well below the peak reached over the past year. That range, combined with the current price of GBX 1,881.50, suggests the market has already re-rated the stock from its lows but has not yet revisited the upper end of the band.

Volume trends were not included in the available source snapshot, so the cleanest near-term read is simply that the stock sits between its annual floor and ceiling while analysts, on average, continue to see room above the current quote.

Conclusion

GSK plc's Sunday setup is defined less by a fresh corporate catalyst than by the combination of a stable London listing, a share price below the average analyst target, and a wide 52-week trading band. If the stock holds near the current level, the next market-moving angle is more likely to come from earnings, guidance, or a bank research update than from the technical picture alone.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.